Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 29, 2009, 10:05AM ET - U.S. Markets close in 5 hours and 55 minutes. Dow  0.17% Nasdaq  0.08%

Hemispherx Biopharma, Inc. (HEB)

At 9:49AM ET: 0.60   0.00 (0.00%)

MORE ON HEB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Fri, Oct 9, 2009 • Hemispherx CEO Carter Speaks: BioBuzz at TheStreet.com (Fri, Oct 9) • Interview With Hemispherx Biopharma's Chief Executive Officer, Dr. William A. Carter Marketwire (Fri, Oct 9) Thu, Oct 8, 2009 • Hemispherx CEO Spills Ampligen Beans to Stock Cheerleader: BioBuzz at TheStreet.com (Thu, Oct 8) • Hemispherx's Ampligen(R)/ Intranasal Flu Vaccine Program to be Presented At International Vaccine Workshop in Osaka GlobeNewswire (Thu, Oct 8) Wed, Oct 7, 2009 • Flu Stocks in Focus as Orders, Approvals Stack Up Indie Research (Wed, Oct 7) • StockPreacher.com Issues Trading Outlook for Hemispherx BioPharma Inc. GlobeNewswire (Wed, Oct 7) Mon, Oct 5, 2009 • Biotechs Gain on Flu Vaccine Hopes at CNBC (Mon, Oct 5) Fri, Oct 2, 2009 • Stanford University Presents New Data On Immuno-Potential of Hemispherx's Ampligen(R) GlobeNewswire (Fri, Oct 2) Mon, Sep 28, 2009 • UPDATE -- Japanese National Institute of Health to Present New Data On Hemispherx's Vaccine Enhancer GlobeNewswire (Mon, Sep 28) Fri, Sep 25, 2009 • Biotech Mailbag: Myriad Pharma at TheStreet.com (Fri, Sep 25) Thu, Sep 24, 2009 • Japanese National Institute of Health to Present New Data on Hemispherx's Vaccine Enhancer GlobeNewswire (Thu, Sep 24) Wed, Sep 23, 2009 • Hemispherx Presents At the Maxim Group Annual Growth Conference GlobeNewswire (Wed, Sep 23) Fri, Sep 18, 2009 • Biotech Stock Mailbag: Cyclacel Pharma at TheStreet.com (Fri, Sep 18) Wed, Sep 16, 2009 • Hemispherx Board of Directors Authorizes Multimillion Dollar Expansion of Its FDA Licensed Manufacturing Facilities GlobeNewswire (Wed, Sep 16) Mon, Sep 14, 2009 • Hemispherx Hasn't Called FDA on Ampligen Review at TheStreet.com (Mon, Sep 14) Thu, Sep 10, 2009 • Swine Flu Biotech Bubble Primed to Burst at TheStreet.com (Thu, Sep 10) Wed, Sep 9, 2009 • Big Weight Loss for Vivus Drug: BioBuzz at TheStreet.com (Wed, Sep 9) • Opexa's Surge a Headscratcher: BioBuzz at TheStreet.com (Wed, Sep 9) Wed, Sep 2, 2009 • Buy Before It's Too Late at Motley Fool (Wed, Sep 2) • Hemispherx Biopharma Presents At the Rodman Healthcare Conference GlobeNewswire (Wed, Sep 2) • Hemispherx Biopharma Announces Cancellation of Adjourned Stockholders' Meeting GlobeNewswire (Wed, Sep 2) Wed, Aug 26, 2009 • Tuesday's Biggest Stock Stars at Motley Fool (Wed, Aug 26) Tue, Aug 18, 2009 • Beacon Equity Issues Trading Outlook for Hemispherx Biopharma Inc. GlobeNewswire (Tue, Aug 18) Mon, Aug 10, 2009 • Hemispherx Biopharma, Inc. 2nd Quarter 2009 Financial Results GlobeNewswire (Mon, Aug 10) • HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Aug 10) Older Headlines - Most Recent Headlines View headlines from: Mon, Aug 10, 2009Mon, Aug 3, 2009Mon, Jul 27, 2009Mon, Jul 20, 2009Mon, Jul 13, 2009Mon, Jul 6, 2009Mon, Jun 29, 2009Mon, Jun 22, 2009Mon, Jun 15, 2009Mon, Jun 8, 2009 Add HEB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage